Ganesh V. Kaundinya
2013
In 2013, Ganesh V. Kaundinya earned a total compensation of $894.8K as Chief Scientific Officer and Senior Vice President, Research at Momenta Pharmaceuticals, which was about the same as previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $154,605 |
|---|---|
| Option Awards | $201,846 |
| Salary | $387,482 |
| Stock Awards | $138,380 |
| Other | $12,474 |
| Total | $894,787 |
Kaundinya received $387.5K in salary, accounting for 43% of the total pay in 2013.
Kaundinya also received $154.6K in non-equity incentive plan, $201.8K in option awards, $138.4K in stock awards and $12.5K in other compensation.
Rankings
In 2013, Ganesh V. Kaundinya's compensation ranked 7,136th out of 12,286 executives tracked by ExecPay. In other words, Kaundinya earned more than 41.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,136 out of 12,286 | 42nd |
Division Manufacturing | 2,542 out of 4,612 | 45th |
Major group Chemicals And Allied Products | 782 out of 1,462 | 47th |
Industry group Drugs | 583 out of 1,156 | 50th |
Industry Biological Products, Except Diagnostic Substances | 94 out of 196 | 52nd |
Source: SEC filing on April 27, 2016.
Kaundinya's colleagues
We found five more compensation records of executives who worked with Ganesh V. Kaundinya at Momenta Pharmaceuticals in 2013.
2013
Craig Wheeler
Momenta Pharmaceuticals
Chief Executive Officer
2013
Michael Franken
Momenta Pharmaceuticals
President, Biosimilars Business and Senior Vice President
2013
James Roach
Momenta Pharmaceuticals
Chief Medical Officer
2013
Bruce Leicher
Momenta Pharmaceuticals
General Counsel
2013
Richard Shea
Momenta Pharmaceuticals